Atossa Genetics Inc logo

ATOS

NASDAQ

Atossa Genetics Inc

Price unavailable — configure POLYGON_API_KEY

Key Statistics
Market Cap$46.20M
P/E RatioN/A
Div. Yield
EPS (TTM)-$4.04
52W High$19.35
52W Low$3.76
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
Employees13
Price Performance
1 Week+13.67%
3 Month-42.05%
1 Year-44.33%
FinancialsAnnual · QuiverQuant
Revenue$0
Assets$96.25M
Liabilities$5.24M
Net Income$30.09M loss

About

Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, discovers and develops drugs in the areas of oncology and infectious diseases. The company is headquartered in Seattle, Washington.

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account
Analyze ATOS with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.